Edgewise Therapeutics, Inc.（EWTX）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Edgewise Therapeutics, Inc.（EWTX）报告了 87 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Fox Jonathan C | 董事 | 买入 | 308 | $0 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | 买入 | 7,031 | $0 |
| 2026-08-14 | MOORE JOHN R | General Counsel | 买入 | 5,781 | $0 |
| 2026-08-14 | Donovan Joanne M. | CMO | 买入 | 5,781 | $0 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | 买入 | 5,781 | $0 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | 买入 | 5,781 | $0 |
| 2026-08-14 | KOCH KEVIN | President and CEO | 买入 | 21,875 | $0 |
| 2026-08-14 | MOORE JOHN R | General Counsel | 买入 | 6,718 | $0 |
| 2026-08-14 | Donovan Joanne M. | CMO | 买入 | 7,031 | $0 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | 买入 | 7,500 | $0 |
| 2026-08-14 | KOCH KEVIN | President and CEO | 买入 | 17,969 | $0 |
| 2026-08-14 | KOCH KEVIN | President and CEO | 卖出 | 8,782 | $383,254 |
| 2026-08-14 | MOORE JOHN R | General Counsel | 卖出 | 2,439 | $106,848 |
| 2026-08-14 | Donovan Joanne M. | CMO | 卖出 | 2,839 | $124,303 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | 卖出 | 2,171 | $95,075 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | 卖出 | 3,238 | $141,428 |
| 2026-08-14 | KOCH KEVIN | President and CEO | 卖出 | 8,276 | $361,315 |
| 2026-08-14 | MOORE JOHN R | General Counsel | 卖出 | 59 | $2,620 |
| 2026-08-14 | Donovan Joanne M. | CMO | 卖出 | 2,779 | $121,463 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | 卖出 | 304 | $13,529 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | 卖出 | 2,273 | $99,275 |
| 2026-08-14 | KOCH KEVIN | President and CEO | 卖出 | 913 | $40,473 |
| 2026-08-14 | MOORE JOHN R | General Counsel | 卖出 | 99 | $4,406 |
| 2026-08-14 | Donovan Joanne M. | CMO | 卖出 | 104 | $4,620 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | 卖出 | 150 | $6,666 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02